Table 2.
Group | Case | Average | Standard Deviation | Variation Coefficient, % | Median | Minimum | Maximum |
---|---|---|---|---|---|---|---|
A | 1 | 3.6 | 4.0 | 112 | 2 | 2 | 15 |
A | 2 | 2.3 | 0.5 | 21 | 2 | 2 | 3 |
A | 3 | 2.8 | 1.2 | 44 | 2 | 2 | 5 |
A | 4 | 5.7 | 3.2 | 57 | 5 | 2 | 13 |
A | 5 | 5.1 | 4.3 | 84 | 3 | 2 | 13 |
A | 6 | 3.2 | 1.0 | 32 | 3 | 2 | 5 |
A | 7 | 2.2 | 0.4 | 19 | 2 | 2 | 3 |
A | 8 | 2.3 | 0.5 | 21 | 2 | 2 | 3 |
A | 9 | 3.6 | 1.7 | 48 | 3 | 2 | 8 |
A | 10 | 7.4 | 2.2 | 29 | 7 | 3 | 12 |
A | 11 | 7.2 | 4.4 | 61 | 8 | 2 | 18 |
B | 1 | 11.2 | 7.1 | 63 | 10 | 5 | 30 |
B | 2 | 10.8 | 8.2 | 76 | 8 | 5 | 30 |
B | 3 | 13.1 | 9.0 | 69 | 10 | 7 | 30 |
B | 4 | 10.9 | 7.1 | 66 | 10 | 5 | 30 |
B | 5 | 18.4 | 10.1 | 55 | 12 | 8 | 30 |
B | 6 | 15.1 | 10.4 | 69 | 9 | 7 | 30 |
B | 7 | 9.7 | 2.2 | 22 | 10 | 7 | 13 |
B | 8 | 19.1 | 6.9 | 36 | 19 | 8 | 30 |
B | 9 | 14.2 | 4.3 | 30 | 14 | 8 | 22 |
B | 10 | 17.3 | 10.0 | 58 | 10 | 8 | 30 |
C | 1 | 9.8 | 7.3 | 74 | 8 | 5 | 30 |
C | 2 | 15.5 | 8.9 | 57 | 13 | 2 | 30 |
C | 3 | 7.4 | 2.4 | 32 | 8 | 2 | 10 |
C | 4 | 6.5 | 2.3 | 36 | 6 | 3 | 10 |
C | 5 | 8.6 | 3.9 | 45 | 7 | 3 | 17 |
C | 6 | 7.6 | 4.9 | 65 | 5 | 3 | 20 |
C | 7 | 12.2 | 9.8 | 80 | 9 | 2 | 30 |
C | 8 | 6.3 | 2.4 | 38 | 6 | 3 | 12 |
C | 9 | 6.0 | 2.3 | 38 | 5 | 2 | 10 |
C | 10 | 6.4 | 5.9 | 92 | 3 | 2 | 18 |
C | 11 | 10.7 | 3.9 | 36 | 10 | 2 | 15 |
C | 12 | 10.8 | 2.2 | 20 | 10 | 8 | 15 |
C | 13 | 15.8 | 5.5 | 35 | 14 | 10 | 25 |
Group A, patients with altered cilia ultrastructure [primary ciliary dyskinesia (PCD) patients]; group B, control group; group C, patients with normal cilia ultrastructure.